INS and diabetes mellitus: There are surprisingly few studies that have comprehensively assessed fasting C‐peptide or other measures of insulin secretion and sensitivity in relation to response to diabetes therapies, and this would seem a likely fruitful area for further study, as C‐peptide is a simple‐to‐measure biomarker that is a useful marker of underlying disease pathophysiology.